Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2.

The Chk2 Ser/Thr kinase plays crucial, evolutionarily conserved roles in cellular responses to DNA damage. Identification of two pro-oncogenic mutations within the Chk2 FHA domain has highlighted its importance for Chk2 function in checkpoint activation. The X-ray structure of the Chk2 FHA domain in complex with an in vitro selected phosphopeptide motif reveals the determinants of binding specificity and shows that both mutations are remote from the peptide binding site. We show that the Chk2 FHA domain mediates ATM-dependent Chk2 phosphorylation and targeting of Chk2 to in vivo binding partners such as BRCA1 through either or both of two structurally distinct mechanisms. Although phospho-dependent binding is important for Chk2 activity, previously uncharacterized phospho-independent FHA domain interactions appear to be the primary target of oncogenic lesions.

[1]  R. Ghirlando,et al.  Crystal Structure of the 14-3-3ζ:Serotonin N-Acetyltransferase Complex A Role for Scaffolding in Enzyme Regulation , 2001, Cell.

[2]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[3]  Thomas C. Terwilliger,et al.  Automated MAD and MIR structure solution , 1999, Acta crystallographica. Section D, Biological crystallography.

[4]  M. Tsai,et al.  II. Structure and specificity of the interaction between the FHA2 domain of Rad53 and phosphotyrosyl peptides. , 2000, Journal of molecular biology.

[5]  M. Yaffe,et al.  Mapping specificity determinants for protein-protein association using protein fusions and random peptide libraries. , 2000, Methods in enzymology.

[6]  S. Elledge,et al.  BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. , 2000, Genes & development.

[7]  T Pawson,et al.  Diversity in protein recognition by PTB domains. , 1999, Current opinion in structural biology.

[8]  S. Elledge,et al.  Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Muir,et al.  Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. , 2001, Molecular cell.

[10]  N. Mailand,et al.  The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis , 2001, Nature.

[11]  John Kuriyan,et al.  Crystal structure of the Src family tyrosine kinase Hck , 1997, Nature.

[12]  D. Sgroi,et al.  Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. , 2001, Cancer research.

[13]  D. Durocher,et al.  The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms. , 2000, Molecular cell.

[14]  DNA Double-Strand Breaks , 2002, The Journal of Experimental Medicine.

[15]  D. Stern,et al.  Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint. , 1998, Science.

[16]  S. Elledge,et al.  Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. , 1998, Science.

[17]  P Bucher,et al.  The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors. , 1995, Trends in biochemical sciences.

[18]  D. Durocher,et al.  The FHA domain is a modular phosphopeptide recognition motif. , 1999, Molecular cell.

[19]  J Kuriyan,et al.  The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. , 2001, Molecular cell.

[20]  D. Delia,et al.  The Forkhead-associated Domain of NBS1 Is Essential for Nuclear Foci Formation after Irradiation but Not Essential for hRAD50·hMRE11·NBS1 Complex DNA Repair Activity* , 2000, The Journal of Biological Chemistry.

[21]  Daniel Durocher,et al.  The FHA domain , 2002, FEBS letters.

[22]  M. Yaffe,et al.  The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity , 1997, Cell.

[23]  S. Carr,et al.  Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway , 1999, Oncogene.

[24]  Ming-Ming Zhou,et al.  Structural basis of SNT PTB domain interactions with distinct neurotrophic receptors. , 2000, Molecular cell.

[25]  P. Russell,et al.  Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cds1 and Chk1. , 1999, Molecular biology of the cell.

[26]  K Cowtan,et al.  Miscellaneous algorithms for density modification. , 1998, Acta crystallographica. Section D, Biological crystallography.

[27]  P. Bates,et al.  Different Smad2 partners bind a common hydrophobic pocket in Smad2 via a defined proline‐rich motif , 2002, The EMBO journal.

[28]  Michael J. Eck,et al.  Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.

[29]  A. Blasina,et al.  Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1 , 2000, Nature Cell Biology.

[30]  Y Taya,et al.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. , 2000, Genes & development.

[31]  Junjie Chen,et al.  Threonine 68 of Chk2 Is Phosphorylated at Sites of DNA Strand Breaks* , 2001, The Journal of Biological Chemistry.

[32]  M. Protopopova,et al.  Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway , 2001, Oncogene.

[33]  A. Blasina,et al.  A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase , 1999, Current Biology.

[34]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[35]  H. Piwnica-Worms,et al.  Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. , 2000, Cancer research.

[36]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[37]  B. Kemp,et al.  FHA domain boundaries of the Dun1p and Rad53p cell cycle checkpoint kinases , 2000, FEBS letters.

[38]  S. Elledge,et al.  DNA damage-induced activation of p53 by the checkpoint kinase Chk2. , 2000, Science.

[39]  Mike Carson,et al.  RIBBONS 2.0 , 1991 .

[40]  M. Tsai,et al.  Structure and function of a new phosphopeptide-binding domain containing the FHA2 of Rad53. , 1999, Journal of molecular biology.

[41]  K. Isselbacher,et al.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.

[42]  A. Murray,et al.  Cell Cycle Checkpoints , 2021, Encyclopedia of Molecular Pharmacology.

[43]  M. Tsai,et al.  Structure of the FHA1 domain of yeast Rad53 and identification of binding sites for both FHA1 and its target protein Rad9. , 2000, Journal of molecular biology.

[44]  T. Halazonetis,et al.  Chfr defines a mitotic stress checkpoint that delays entry into metaphase , 2000, Nature.

[45]  H. Piwnica-Worms,et al.  A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Halazonetis,et al.  Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. , 2000, Genes & development.

[47]  J J Correia,et al.  Structural basis of Smad1 activation by receptor kinase phosphorylation. , 2001, Molecular cell.

[48]  J. Massagué,et al.  Structural basis of Smad2 recognition by the Smad anchor for receptor activation. , 2000, Science.

[49]  L. Hartwell,et al.  Checkpoints: controls that ensure the order of cell cycle events. , 1989, Science.

[50]  J. Parvin,et al.  Redistribution of BRCA1 among Four Different Protein Complexes following Replication Blockage* , 2001, The Journal of Biological Chemistry.

[51]  P. Russell,et al.  Threonine-11, Phosphorylated by Rad3 and ATM In Vitro, Is Required for Activation of Fission Yeast Checkpoint Kinase Cds1 , 2001, Molecular and Cellular Biology.

[52]  K. Khanna,et al.  The Plant Isoflavenoid Genistein Activates p53 and Chk2 in an ATM-dependent Manner* , 2001, The Journal of Biological Chemistry.

[53]  Jay H. Chung,et al.  The hCds1 (Chk2)-FHA Domain Is Essential for a Chain of Phosphorylation Events on hCds1 That Is Induced by Ionizing Radiation* , 2001, The Journal of Biological Chemistry.

[54]  K. Khanna,et al.  DNA double-strand breaks: signaling, repair and the cancer connection , 2001, Nature Genetics.

[55]  Stephen J. Elledge,et al.  Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.

[56]  Jong-Soo Lee,et al.  hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response , 2000, Nature.

[57]  S. Elledge,et al.  The DNA damage response: putting checkpoints in perspective , 2000, Nature.

[58]  S. Moreno,et al.  Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1 , 1998, Nature.

[59]  M. Yaffe,et al.  PhosphoSerine/threonine binding domains: you can't pSERious? , 2001, Structure.

[60]  C. Gilbert,et al.  Budding yeast Rad9 is an ATP-dependent Rad53 activating machine. , 2001, Molecular cell.

[61]  Jing Chen,et al.  Characterization of Tumor-associated Chk2 Mutations* , 2001, The Journal of Biological Chemistry.